Stay updated on T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial

Sign up to get notified when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.1 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-02T00:26:20.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.1.
    Difference
    0.0%
    Check dated 2025-04-24T17:31:05.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates regarding a clinical study on trastuzumab deruxtecan, including the addition of new identifiers and a description of the study's treatment arms, while removing detailed eligibility criteria and study objectives.
    Difference
    12%
    Check dated 2025-04-17T12:04:27.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page has updated its version from v2.14.3 to v2.14.4, indicating a new release. Additionally, the previous estimated timestamps for 'Results First Posted' and 'Last Update Posted' have been removed.
    Difference
    0.1%
    Check dated 2025-04-10T10:08:31.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated to include detailed assessments of Progression-Free Survival (PFS) and Overall Survival (OS) in various populations, with specific methodologies and timelines for evaluations. Additionally, there are new definitions and metrics for Objective Response Rate (ORR) and Duration of Response (DOR), enhancing the clarity and comprehensiveness of the clinical study results.
    Difference
    61%
    Check dated 2025-04-03T01:11:08.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, replacing the previous estimated date of January 15, 2025.
    Difference
    0.1%
    Check dated 2025-03-26T17:57:14.000Z thumbnail image

Stay in the know with updates to T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.